Immix Biopharma, Inc. (IMMX:NASDAQ) closed at $8.35 on October 22, 2026, down 1.88% on the day. The stock trades 44.7% below its 52-week high of $15.10 and 192.9% above its 52-week low of $2.85. Over the past year, it gained 175.4%. Immix Biopharma, Inc. is part of the Health Care sector.
In 252 trading sessions since October 21, 2025, IMMX closed higher on 127 days (50%). Its best day was December 4, 2025 (+16.63%) and its worst was March 18, 2026 (-14.93%). The stock moved 10% or more in a single session 18 times. It opened at least 5% above the previous day's high 1 time.
Immix Biopharma Inc is a clinical-stage biopharmaceutical company developing Tissue-Specific Therapeutics in oncology and inflammation.
Find more stocks like IMMX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.